Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study

Purpose To compare results in patients treated with additional radiofrequency ablation (RFA) after clinical evaluation or vital volume (Va) increase. Methods Forty patients with 42 benign thyroid nodules who underwent additional RFA were evaluated in this retrospective study. According to the differ...

Full description

Bibliographic Details
Main Authors: Lin Yan, Yukun Luo, Mingbo Zhang, Jing Xiao
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:International Journal of Hyperthermia
Subjects:
Online Access:http://dx.doi.org/10.1080/02656736.2020.1778197
id doaj-4081e41f1f1b440e98c8b10fab423381
record_format Article
spelling doaj-4081e41f1f1b440e98c8b10fab4233812021-08-09T15:50:02ZengTaylor & Francis GroupInternational Journal of Hyperthermia0265-67361464-51572020-01-0137177778510.1080/02656736.2020.17781971778197Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective studyLin Yan0Yukun Luo1Mingbo Zhang2Jing Xiao3Department of Ultrasound, First Medical Center, Chinese PLA General HospitalDepartment of Ultrasound, First Medical Center, Chinese PLA General HospitalDepartment of Ultrasound, First Medical Center, Chinese PLA General HospitalDepartment of Ultrasound, First Medical Center, Chinese PLA General HospitalPurpose To compare results in patients treated with additional radiofrequency ablation (RFA) after clinical evaluation or vital volume (Va) increase. Methods Forty patients with 42 benign thyroid nodules who underwent additional RFA were evaluated in this retrospective study. According to the different indication for additional RFA, 18 patients were divided into Vv increase group (V group) and 22 into clinical evaluation group (C group). Patients were followed up at 1, 3, 6, 12 months and every 12 months thereafter by conventional ultrasound (US), contrast-enhancement ultrasound (CEUS) and clinical evaluation. Volume, volume reduction rate (VRR), symptom score and cosmetic score were evaluated before treatment and each ablation. Results After the first RFA, there were no statistically differences between two groups in volume, VRR, cosmetic and symptom scores. Compared with the first RFA, volume of all the patients after additional RFA decreased significantly (p < 0.001). In additional RFA, during a mean follow-up time of 10.15 ± 9.17 months, volume in V group was significantly smaller than in C group (2.84 ± 5.43 ml Vs 7.39 ± 13.01 ml, p = 0.046). VRR in V group was significantly larger than in C group (90.18 ± 12.74% Vs 75.66 ± 26.47%, p = 0.007) with significant improvement of cosmetic and symptom scores (p = 0.047; p = 0.030). No complications occurred after each session ablation. Conclusion Vv increase was a more reliable indicator for additional RFA than clinical evaluation. Additional RFA performed after Vv increase was more effective with respect to volume reduction and improvement of clinical outcomes. Therefore, Vv increase should be set as an indication for additional RFA.http://dx.doi.org/10.1080/02656736.2020.1778197radiofrequency ablationthyroid nodulesadditionalultrasoundvital volumecontrast-enhanced ultrasound
collection DOAJ
language English
format Article
sources DOAJ
author Lin Yan
Yukun Luo
Mingbo Zhang
Jing Xiao
spellingShingle Lin Yan
Yukun Luo
Mingbo Zhang
Jing Xiao
Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study
International Journal of Hyperthermia
radiofrequency ablation
thyroid nodules
additional
ultrasound
vital volume
contrast-enhanced ultrasound
author_facet Lin Yan
Yukun Luo
Mingbo Zhang
Jing Xiao
author_sort Lin Yan
title Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study
title_short Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study
title_full Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study
title_fullStr Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study
title_full_unstemmed Vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study
title_sort vital volume increase versus clinical evaluation as the indication of additional radiofrequency ablation for benign thyroid nodule: a single center retrospective study
publisher Taylor & Francis Group
series International Journal of Hyperthermia
issn 0265-6736
1464-5157
publishDate 2020-01-01
description Purpose To compare results in patients treated with additional radiofrequency ablation (RFA) after clinical evaluation or vital volume (Va) increase. Methods Forty patients with 42 benign thyroid nodules who underwent additional RFA were evaluated in this retrospective study. According to the different indication for additional RFA, 18 patients were divided into Vv increase group (V group) and 22 into clinical evaluation group (C group). Patients were followed up at 1, 3, 6, 12 months and every 12 months thereafter by conventional ultrasound (US), contrast-enhancement ultrasound (CEUS) and clinical evaluation. Volume, volume reduction rate (VRR), symptom score and cosmetic score were evaluated before treatment and each ablation. Results After the first RFA, there were no statistically differences between two groups in volume, VRR, cosmetic and symptom scores. Compared with the first RFA, volume of all the patients after additional RFA decreased significantly (p < 0.001). In additional RFA, during a mean follow-up time of 10.15 ± 9.17 months, volume in V group was significantly smaller than in C group (2.84 ± 5.43 ml Vs 7.39 ± 13.01 ml, p = 0.046). VRR in V group was significantly larger than in C group (90.18 ± 12.74% Vs 75.66 ± 26.47%, p = 0.007) with significant improvement of cosmetic and symptom scores (p = 0.047; p = 0.030). No complications occurred after each session ablation. Conclusion Vv increase was a more reliable indicator for additional RFA than clinical evaluation. Additional RFA performed after Vv increase was more effective with respect to volume reduction and improvement of clinical outcomes. Therefore, Vv increase should be set as an indication for additional RFA.
topic radiofrequency ablation
thyroid nodules
additional
ultrasound
vital volume
contrast-enhanced ultrasound
url http://dx.doi.org/10.1080/02656736.2020.1778197
work_keys_str_mv AT linyan vitalvolumeincreaseversusclinicalevaluationastheindicationofadditionalradiofrequencyablationforbenignthyroidnoduleasinglecenterretrospectivestudy
AT yukunluo vitalvolumeincreaseversusclinicalevaluationastheindicationofadditionalradiofrequencyablationforbenignthyroidnoduleasinglecenterretrospectivestudy
AT mingbozhang vitalvolumeincreaseversusclinicalevaluationastheindicationofadditionalradiofrequencyablationforbenignthyroidnoduleasinglecenterretrospectivestudy
AT jingxiao vitalvolumeincreaseversusclinicalevaluationastheindicationofadditionalradiofrequencyablationforbenignthyroidnoduleasinglecenterretrospectivestudy
_version_ 1721213868331499520